BRLS vs RMCF

The company exhibits severe financial distress with a Piotroski F-Score of just 1/9, indicating very weak fundamental health. Profitability metrics are deeply negative, with a -65.72% profit margin and -13.56% ROA, while liquidity is critically impaired (Current Ratio: 0.15, Quick Ratio: 0.04). Revenue is declining YoY (-7.60%), and the stock has lost over 90% of its value in the past three years. Despite a low Price/Sales ratio of 0.75, the absence of reliable earnings, cash flow, and balance sheet data, combined with no Graham or Altman scores, suggests extreme risk.

RMCF exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of operational health metrics. The company is destroying shareholder value with a staggering ROE of -50.96% and negative profit margins of -13.62%. While the stock has seen a speculative 1-year price increase of 74.4%, this is decoupled from fundamentals as revenue continues to shrink (-4.40% YoY). The combination of high leverage (Debt/Equity 1.54) and bearish insider selling suggests a high risk of further deterioration.